Thoracoscopic Ablation for Lone Atrial Fibrillation

A phase 3 trial registered on ClinicalTrials.gov. The registry status is unknown. It enrolled 232 participants.

Also called NCT05708027

  • Study
  • In this atlas

Overview

Design
Interventional study; non-randomized; no masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 232 participants (enrolled count) (from the registry)
Sponsor
Federal Research Clinical Center of Federal Medical & Biological Agency, Russia (from the registry)
Registry
  • NCT NCT05708027
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Russia (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT05708027. Non-randomized; no masking; primary purpose treatment. Start 2021-01-06 (actual); primary completion 2022-08-31 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Thoracoscopic Ablation for Lone Atrial Fibrillation
Condition
Heart Diseases
Intervention (Procedure)
Thoracoscopic surgical ablation
Lead sponsor
Federal Research Clinical Center of Federal Medical & Biological Agency, Russia (class: other government)
Collaborator
Federal State Budget Institution Clinical Hospital, Moscow, Russia (class: not stated)

Record details

Record id
cardio:ct-nct05708027
Content hash
beeabffacbe2a213fbffd94f8e1d6a5d80935a7f6147d28716e4265e01b621ed